Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA Collaboration
Access
info:eu-repo/semantics/closedAccessDate
2019Author
Ornbjerg, Lykke MidtbollAskling, Johan
Loft, Anne Gitte
Nissen, Michael J.
Mann, Herman
Direskeneli, Haner
Ostergaard, Mikkel
Metadata
Show full item recordAbstract
[No abstract available]